Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Assets (2016 - 2025)

CorMedix has reported Current Assets over the past 15 years, most recently at $367.1 million for Q4 2025.

  • Quarterly results put Current Assets at $367.1 million for Q4 2025, up 220.36% from a year ago — trailing twelve months through Dec 2025 was $367.1 million (up 220.36% YoY), and the annual figure for FY2025 was $367.1 million, up 220.36%.
  • Current Assets reached $367.1 million in Q4 2025 per CRMD's latest filing, up from $259.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $367.1 million in Q4 2025 and bottomed at $53.2 million in Q2 2024.
  • Median Current Assets over the past 5 years was $73.1 million (2021), compared with a mean of $107.7 million.
  • The largest annual shift saw Current Assets fell 24.75% in 2022 before it soared 366.32% in 2025.
  • Over 5 years, Current Assets stood at $66.5 million in 2021, then fell by 10.41% to $59.6 million in 2022, then skyrocketed by 33.42% to $79.5 million in 2023, then soared by 44.21% to $114.6 million in 2024, then surged by 220.36% to $367.1 million in 2025.
  • Business Quant data shows Current Assets for CRMD at $367.1 million in Q4 2025, $259.5 million in Q3 2025, and $248.1 million in Q2 2025.